Agents to control bleeding show promise.
Hampton
Tracy
T
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000925:Anticoagulants / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D000069604:Dabigatran; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006401:Hematologic Agents / Q000627:therapeutic use*; D006801:Humans; D009844:Oligosaccharides / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000517:prevention & control; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use; D053628:Receptors, Thrombopoietin; D000069283:Rituximab; D020246:Venous Thrombosis / Q000517:prevention & control*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000925:Anticoagulants; D001562:Benzimidazoles; D005343:Fibrinolytic Agents; D006401:Hematologic Agents; D009844:Oligosaccharides; D011725:Pyridines; D053628:Receptors, Thrombopoietin; D000069283:Rituximab; C479958:idraparinux; D000069604:Dabigatran